Anti-SGCZ monoclonal antibody

Pre-made anti-SGCZ monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SGCZ/SGCZ products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1628-Ab-1/ GM-Tg-hg-IP1628-Ab-2Anti-Human SGCZ monoclonal antibodyHuman
GM-Tg-rg-IP1628-Ab-1/ GM-Tg-rg-IP1628-Ab-2Anti-Rat SGCZ monoclonal antibodyRat
GM-Tg-mg-IP1628-Ab-1/ GM-Tg-mg-IP1628-Ab-2Anti-Mouse SGCZ monoclonal antibodyMouse
GM-Tg-cynog-IP1628-Ab-1/ GM-Tg-cynog-IP1628-Ab-2Anti-Cynomolgus/ Rhesus macaque SGCZ monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1628-Ab-1/ GM-Tg-felg-IP1628-Ab-2Anti-Feline SGCZ monoclonal antibodyFeline
GM-Tg-cang-IP1628-Ab-1/ GM-Tg-cang-IP1628-Ab-2Anti-Canine SGCZ monoclonal antibodyCanine
GM-Tg-bovg-IP1628-Ab-1/ GM-Tg-bovg-IP1628-Ab-2Anti-Bovine SGCZ monoclonal antibodyBovine
GM-Tg-equg-IP1628-Ab-1/ GM-Tg-equg-IP1628-Ab-2Anti-Equine SGCZ monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1628-Ab-1/ GM-Tg-hg-IP1628-Ab-2; GM-Tg-rg-IP1628-Ab-1/ GM-Tg-rg-IP1628-Ab-2;
GM-Tg-mg-IP1628-Ab-1/ GM-Tg-mg-IP1628-Ab-2; GM-Tg-cynog-IP1628-Ab-1/ GM-Tg-cynog-IP1628-Ab-2;
GM-Tg-felg-IP1628-Ab-1/ GM-Tg-felg-IP1628-Ab-2; GM-Tg-cang-IP1628-Ab-1/ GM-Tg-cang-IP1628-Ab-2;
GM-Tg-bovg-IP1628-Ab-1/ GM-Tg-bovg-IP1628-Ab-2; GM-Tg-equg-IP1628-Ab-1/ GM-Tg-equg-IP1628-Ab-2
Products NameAnti-SGCZ monoclonal antibody
Formatmab
Target NameSGCZ
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SGCZ monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1628-Ag-1Recombinant multi-species SGCZ/ ZSG1 protein


    Target information

    Target IDGM-IP1628
    Target NameSGCZ
    Gene ID137868,244431,364605,100430474,482890,101086054,100049909
    Gene Symbol and SynonymsC230085N17Rik,SGCZ,ZSG1
    Uniprot AccessionQ96LD1
    Uniprot Entry NameSGCZ_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000185053
    Target ClassificationN/A

    The target: SGCZ, gene name: SGCZ, also named as ZSG1. The zeta-sarcoglycan gene measures over 465 kb and localizes to 8p22. This protein is part of the sarcoglycan complex, a group of 6 proteins. The sarcoglycans are all N-glycosylated transmembrane proteins with a short intra-cellular domain, a single transmembrane region and a large extra-cellular domain containing a carboxyl-terminal cluster with several conserved cysteine residues. The sarcoglycan complex is part of the dystrophin-associated glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extra-cellular matrix. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.